Introduction
Open surgical repair of Achilles tendon ruptures is traditionally associated with risks such as skin necrosis and infection. Recent advances have led to the adoption of percutaneous repair techniques, which minimize these risks by preserving the critical hematoma phase of tendon healing. This approach allows sutures and knots to remain beneath the skin, thereby reducing healing time and the risk of infection.
Material And Methods
Between January 2017 and May 2024, 42 male patients (mean age: 42.4 years) with acute Achilles tendon ruptures underwent percutaneous repair under local anesthesia. The repair utilized a single or double absorbable suture in a "double square" configuration. Postoperatively, patients were immobilized in a cast fixed in the equinus position for 3 weeks, followed by 3 weeks in a functional orthosis with three heels. Patients were evaluated using the Visual Analogue Scale (VAS) at the time of surgery and at 3-month follow-up, as well as the Achilles Tendon Rupture Score (ATRS) and the American Orthopaedic Foot & Ankle Society (AOFAS) Ankle-Hindfoot Score at 3 and 6 months postoperatively.
Results
The mean follow-up period was 34 months. Complications included 1 case of re-rupture at 3 months and 2 cases of superficial wound infection. Notably, no sural nerve lesions were reported. The mean time to return to work was 78 days. Clinical outcomes were favorable, with no significant loss of range of motion. The mean VAS scores were 2.54 (SD: 0.79) at the time of surgery and 1.87 (SD: 1.32) at 3 months postoperatively. The mean ATRS scores were 92.25 (SD: 6.34) at 3 months and 92.04 (SD: 4.37) at 6 months. The mean AOFAS scores were 88 (SD: 5.93) at 3 months and 95.42 (SD: 3.62) at 6 months.
Conclusions
Percutaneous Achilles tendon repair under local anesthesia is a low-cost, effective technique that promotes optimal healing by preserving the natural phases of tendon repair. It is associated with fewer wound complications, shorter hospital stays, and quicker return to work, making it a leading treatment option for acute Achilles tendon ruptures.